Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2020 09:30 ET | Source: Precipio, Inc.

Company Update During the COVID-19 Era

NEW HAVEN, Conn., March 20, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), released today the following letter to shareholders from its CEO, Ilan Danieli. ...
March 16, 2020 09:30 ET | Source: Precipio, Inc.

Precipio Completes the Transaction with Poplar Healthcare’s Oncometrix Hematopathology Division

NEW HAVEN, Conn., March 16, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has completed the non-cash transaction of the transition of...
February 26, 2020 11:30 ET | Source: Precipio, Inc.

Precipio achieves impressive initial results of Artificial Intelligence Decision-Support Tool

Groundbreaking clinical and economic impact to be generated NEW HAVEN, Conn., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that...
February 18, 2020 10:00 ET | Source: Precipio, Inc.

Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership

NEW HAVEN, Conn., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it is in advanced discussions with Poplar Healthcare to...
January 28, 2020 07:30 ET | Source: Precipio, Inc.

Precipio Provides Clarification To Amendment No.1 to Form S-1 Filing

NEW HAVEN, Conn., Jan. 28, 2020 (GLOBE NEWSWIRE) -- The management team of Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), would like to provide an explanation on the recent Amendment...
January 15, 2020 07:30 ET | Source: Precipio, Inc.

Precipio Provides Clarification To Recent S-1 Filing

NEW HAVEN, Conn., Jan. 15, 2020 (GLOBE NEWSWIRE) -- The management team of Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), would like to provide several clarification points related to...
January 13, 2020 17:00 ET | Source: Precipio, Inc.

Precipio announces shareholder update call to kick off 2020

NEW HAVEN, Conn., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that on Monday, January 20th at 5pm it will conduct a shareholder update...
September 30, 2019 11:10 ET | Source: Precipio, Inc.

First Substantial Customer: Tennessee Oncology Internalizes Precipio’s HemeScreen™

NEW HAVEN, Conn., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that Tennessee Oncology has selected Precipio’s HemeScreen RUO assay as...
September 26, 2019 10:53 ET | Source: Precipio, Inc.

Clinical Validations for IV-Cell™ and HemeScreen™ Completed

Orders expected from several major labs both domestically and internationally NEW HAVEN, Conn., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO),...
September 05, 2019 09:15 ET | Source: Precipio, Inc.

Precipio and University of Pennsylvania Enter into Joint Collaboration Agreement for Pathology Diagnostics

NEW HAVEN, Conn., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Specialty Diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today a major development toward expanding cancer patient access to world...